Acciones Infant Bacterial Therapeutics AB (publ) Other OTC
Acciones
Farmacéuticos
Ventas 2022 | - | Ventas 2023 | 0,08 0,07 | Capitalización | 1212,43 M 1117,96 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -65 M -59,94 M | Resultado Neto 2023 | -123 M -113 M | VE / Ventas 2022 | - |
Posición de caja neta 2022 | 336 M 310 M | Posición de caja neta 2023 | 329 M 303 M | VE / Ventas 2023 | 11.472.257.143 x |
P/E ratio 2022 |
-8,58
x | P/E ratio 2023 |
-9,04
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 87,87 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 57 | 01/01/13 | |
Maria Ekdahl
DFI | Director of Finance/CFO | 51 | 19/09/22 |
Chief Operating Officer | 57 | 20/10/14 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Margareta Hagman
BRD | Director/Board Member | 58 | 24/09/15 |
Chairman | 74 | 01/01/11 | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 04/05/17 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+15,54 % | 78,51 mil M | |
+12,05 % | 9001,54 M | |
+58,17 % | 4961 M | |
-14,94 % | 4836,07 M | |
-.--% | 3724,31 M | |
+21,94 % | 2477,65 M | |
-26,63 % | 2185,43 M | |
+16,75 % | 2116,73 M | |
-37,97 % | 1942,03 M |